Influenza hemagglutinin and neuraminidase variants

US7504109B2 · kind B2 · utility

Assignees

• MedImmune Limited · US
• The United States of America as Represented by The Department of Health Services, National Institute of Health · US

Inventors

• Chin-Fen Yang · San Jose, US
• George Kemble · Saratoga, US
• Kanta Subbarao · Washington, US
• Brian Philip Murphy · Tampa, US

Key dates

• Filing date: May 20, 2005
• Grant date: Mar 17, 2009
• Expiry date: May 20, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2760/16171
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.